Inventor · disambiguated record
Mamoru Matsuda
Also filed as: MATSUDA MAMORU
15 granted patents·1 pending application·19 citations·filing 2006–2013
89Inventor score
Technology areasA61P
Top patents by PatentIndex Score
16 records- 0178US8017775B21-2-dihydroquinoline derivative having glucocorticoid receptor binding activitySANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Sep 13, 2011·3 cites·35 claims
- 0277US8551991B21,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activityMATSUDA MAMORU·Filed 2007·Granted Oct 8, 2013·3 cites·17 claims
- 0377US8193187B21,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activityMATSUDA MAMORU·Filed 2008·Granted Jun 5, 2012·3 cites·15 claims
- 0474US8008498B21,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituentsSANTEN PHARMACEUTICAL CO LTD·Filed 2007·Granted Aug 30, 2011·1 cites·8 claims
- 0573US9062061B2Compound having PARP inhibitory activityHONDA TAKAHIRO·Filed 2012·Granted Jun 23, 2015·4 cites·18 claims
- 0670US8664221B2Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituentKATO MASATOMO·Filed 2009·Granted Mar 4, 2014·2 cites·8 claims
- 0768US8569493B2Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compoundMATSUDA MAMORU·Filed 2012·Granted Oct 29, 2013·1 cites·12 claims
- 0866US8426406B2Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy groupKATO MASATOMO·Filed 2009·Granted Apr 23, 2013·2 cites·17 claims
- 0964US8008497B21,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituentsSANTEN PHARMACEUTICAL CO LTD·Filed 2007·Granted Aug 30, 2011·0 cites·9 claims
- 1064US8008496B21,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituentsSANTEN PHARMACEUTICAL CO LTD·Filed 2007·Granted Aug 30, 2011·0 cites·95 claims
- 1157US8580784B2Method for treating a disease related to the glucocorticoid receptorMATSUDA MAMORU·Filed 2011·Granted Nov 12, 2013·0 cites·7 claims
- 1257US8440660B2Method for treating a disease related to the glucocorticoid receptorMATSUDA MAMORU·Filed 2011·Granted May 14, 2013·0 cites·9 claims
- 1356US8563551B2Method for preventing or treating a disease related to the glucocorticoid receptorMATSUDA MAMORU·Filed 2011·Granted Oct 22, 2013·0 cites·8 claims
- 1451US8975256B21,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activitySANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Mar 10, 2015·0 cites·5 claims
- 1548US2014045842A1Method for treating an inflammatory disease by administering a 1,2,3,4-tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituentSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1646US8420635B2Method for preventing or treating a glucocorticoid receptor-related diseaseMATSUDA MAMORU·Filed 2011·Granted Apr 16, 2013·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Mamoru Matsuda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →